{"id":381493,"date":"2020-11-16T07:18:17","date_gmt":"2020-11-16T12:18:17","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381493"},"modified":"2020-11-16T07:18:17","modified_gmt":"2020-11-16T12:18:17","slug":"liquidia-announces-results-of-special-meeting-of-stockholders","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/","title":{"rendered":"Liquidia Announces Results of Special Meeting of Stockholders"},"content":{"rendered":"
\n

\n Stockholders <\/em>
\n Approve RareGen <\/em>
\n Acquisition<\/em>
\n \n <\/p>\n

\n Merger Expected to <\/em>
\n Close on<\/em>
\n or <\/em>
\n A<\/em>
\n bout <\/em>
\n November <\/em>
\n 18<\/em>
\n , 2020<\/em>\n <\/p>\n

RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT\u00ae\u00a0technology, today announced that its stockholders voted to adopt and approve the previously announced merger agreement, dated as of June 29, 2020, among the Company, RareGen, LLC (\u201cRareGen\u201d), Liquidia Corporation (\u201cLiquidia Corporation\u201d), Gemini Merger Sub I, Inc. (\u201cLiquidia Merger Sub\u201d), Gemini Merger Sub II, LLC and PBM RG Holdings, LLC (the \u201cMerger Agreement\u201d), including the merger of the Company with and into Liquidia Merger Sub (the \u201cLiquidia Merger\u201d), with the Company and RareGen surviving as wholly owned subsidiaries of Liquidia Corporation post-merger, at a special meeting of stockholders held on November 13, 2020. In addition, Liquidia stockholders voted to approve all other matters related to the Merger Agreement and the Liquidia Merger.<\/p>\n

At the close of business on September 14, 2020, the record date for the special meeting, there were 37,752,027 shares of Company common stock outstanding. Approximately 71 percent of the shares outstanding as of September 14, 2020 voted to adopt and approve the Merger Agreement. Further, among other proposals, stockholders voted to approve the Liquidia Corporation 2020 Long-Term Incentive Plan and the Liquidia Corporation 2020 Employee Stock Purchase Plan, both of which will be effective upon completion of the merger.<\/p>\n

The closing of the merger transaction is expected to occur on or about November 18, 2020, subject to the satisfaction of the closing conditions set forth in the Merger Agreement.<\/p>\n

\n About\u00a0Liquidia<\/strong>
\n
Liquidia\u00a0is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT\u00ae technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. Currently,\u00a0Liquidia\u00a0is focused on the development of two product candidates for which it holds worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain.\u00a0Liquidia\u00a0is headquartered in\u00a0Research Triangle Park, NC. For more information, please visit\u00a0www.liquidia.com<\/a><\/u>.<\/p>\n

\n About RareGen<\/strong>
\n
RareGen, LLC is a portfolio company of\u00a0PBM Capital Group, a healthcare investment firm. RareGen provides strategy, investment, and commercialization for rare disease pharmaceutical products. RareGen has a national sales force focused on cardiology and pulmonology specialties.<\/p>\n

\n Important Information About the Transaction and Where to Find It<\/strong>
\n
In connection with the proposed merger transaction,\u00a0the Company\u00a0and Liquidia Corporation have filed documents with the\u00a0SEC, including the filing by\u00a0Liquidia Corporation\u00a0of a registration statement on Form\u00a0S-4, which was declared effective on September 16, 2020, and a final proxy statement\/prospectus (including the supplements thereto), and\u00a0the Company\u00a0mailed a proxy statement (and supplements thereto) regarding the proposed merger transaction to its stockholders that also constitutes a prospectus of\u00a0the Company. This document is not a substitute for the proxy statement\/prospectus or registration statement or any other document which\u00a0the Company or Liquidia Corporation\u00a0have filed with the SEC.\u00a0Investors and security holders of<\/strong>\u00a0<\/strong>the Company<\/strong>\u00a0<\/strong>and RareGen are urged to read the registration statement, the proxy statement\/prospectus and any other relevant documents, as well as any amendments or supplements to these documents, carefully and in their entirety because they will contain important information<\/strong>. Investors and security holders may obtain free copies of the registration statement and the proxy statement\/prospectus and other documents filed with the\u00a0SEC\u00a0by\u00a0the Company through the website maintained by the\u00a0SEC\u00a0at\u00a0www.sec.gov<\/a>\u00a0or by contacting the investor relations department of\u00a0the Company at the following:<\/p>\n

Liquidia Technologies, Inc.
Jason Adair
Investor Relations
(919) 328-4350
Jason.adair@liquidia.com<\/a><\/p>\n

\n Participants in the Solicitation<\/strong>
\n
The Company, RareGen and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction and related matters. Information regarding the Company\u2019s directors and executive officers, including a description of their direct interests, by security holdings or otherwise, is contained in the Company\u2019s Form 10-K for the year ended\u00a0December\u00a031, 2019\u00a0and its proxy statement filed on\u00a0April 28, 2020, which are filed with the\u00a0SEC. Additional information is available in the registration statement on Form S-4 and the proxy statement\/prospectus (as supplemented).<\/p>\n

\n No Offer or Solicitation<\/strong>
\n
This communication is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section\u00a010 of the Securities Act of 1933, as amended.<\/p>\n

\n Cautionary Statements Regarding Forward Looking Statements\u00a0<\/strong>
\n
This communication contains \u201cforward-looking statements\u201d within the meaning of the federal securities laws, including Section\u00a027A of the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), and Section\u00a021E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as \u201cexpect,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cseek,\u201d \u201csee,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201ctarget,\u201d similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the potential timing or consummation of the proposed merger transaction or the anticipated benefits thereof, including, without limitation, future financial and operating results. The Company cautions readers that these and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to risks and uncertainties related to (i)\u00a0the risk that a condition to closing of the merger transaction may not be satisfied, (ii)\u00a0the ability of the Company and RareGen to integrate their businesses successfully and to achieve anticipated cost savings and other synergies, (iii)\u00a0the possibility that other anticipated benefits of the proposed merger transaction will not be realized, including without limitation, anticipated revenues, expenses, earnings and other financial results, and growth and expansion of the new combined company\u2019s operations, and the anticipated tax treatment, (iv)\u00a0potential litigation relating to the proposed merger transaction that has and could be instituted against the Company, RareGen or their respective officers or directors, (v)\u00a0possible disruptions from the proposed merger transaction that could harm the Company\u2019s or RareGen\u2019s business, including current plans and operations, (vi)\u00a0the ability of the Company or RareGen to retain, attract and hire key personnel, (vii)\u00a0potential adverse reactions or changes to relationships with employees, customers, suppliers, licensees, collaborators, business partners or other parties resulting from the announcement or completion of the merger transaction, (viii)\u00a0potential business uncertainty, including changes to existing business relationships, during the pendency of the merger transaction that could affect the Company\u2019s and\/or RareGen\u2019s financial performance, (ix)\u00a0certain restrictions during the pendency of the merger transaction that may impact the Company\u2019s or RareGen\u2019s ability to pursue certain business opportunities or strategic transactions, (x)\u00a0continued availability of capital and financing and rating agency actions, (xi)\u00a0legislative, regulatory and economic developments and (xii)\u00a0unpredictability and severity of catastrophic events, including, but not limited to, global pandemics such as coronavirus, acts of terrorism or outbreak of war or hostilities, as well as management\u2019s response to any of the aforementioned factors. These risks, as well as other risks associated with the proposed merger transaction, as more fully discussed in the proxy statement\/prospectus in connection with the proposed merger transaction, which was declared effective on September 16, 2020, as subsequently supplemented. While the list of factors presented here is, and the list of factors to be presented in the registration statement on Form S-4 are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on the Company\u2019s or RareGen\u2019s consolidated financial condition, results of operations, credit rating or liquidity. Neither the Company nor RareGen assumes any obligation to provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.<\/p>\n

\n Contact Information<\/strong><\/p>\n

Media<\/strong>:
Michael Parks
Corporate Communications
484.356.7105
michael.parks@liquidia.com<\/u><\/a><\/p>\n

\n Investors<\/strong>:
Jason Adair
Vice President, Corporate Development and Strategy
919.328.4400
jason.adair@liquidia.com<\/a><\/u><\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Stockholders Approve RareGen Acquisition Merger Expected to Close on or A bout November 18 , 2020 RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT\u00ae\u00a0technology, today announced that its stockholders voted to adopt and approve the previously announced merger agreement, dated as of June 29, 2020, among the Company, RareGen, LLC (\u201cRareGen\u201d), Liquidia Corporation (\u201cLiquidia Corporation\u201d), Gemini Merger Sub I, Inc. (\u201cLiquidia Merger Sub\u201d), Gemini Merger Sub II, LLC and PBM RG Holdings, LLC (the \u201cMerger Agreement\u201d), including the merger of the Company with and into Liquidia Merger Sub (the \u201cLiquidia Merger\u201d), with the Company and … <\/p>\n

Continue reading “Liquidia Announces Results of Special Meeting of Stockholders”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381493","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLiquidia Announces Results of Special Meeting of Stockholders - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Liquidia Announces Results of Special Meeting of Stockholders - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Stockholders Approve RareGen Acquisition Merger Expected to Close on or A bout November 18 , 2020 RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT\u00ae\u00a0technology, today announced that its stockholders voted to adopt and approve the previously announced merger agreement, dated as of June 29, 2020, among the Company, RareGen, LLC (\u201cRareGen\u201d), Liquidia Corporation (\u201cLiquidia Corporation\u201d), Gemini Merger Sub I, Inc. (\u201cLiquidia Merger Sub\u201d), Gemini Merger Sub II, LLC and PBM RG Holdings, LLC (the \u201cMerger Agreement\u201d), including the merger of the Company with and into Liquidia Merger Sub (the \u201cLiquidia Merger\u201d), with the Company and … Continue reading "Liquidia Announces Results of Special Meeting of Stockholders"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-16T12:18:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjQxNyMzODI4MzM1IzIwODQ0NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Liquidia Announces Results of Special Meeting of Stockholders\",\"datePublished\":\"2020-11-16T12:18:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/\"},\"wordCount\":1520,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjQxNyMzODI4MzM1IzIwODQ0NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/\",\"name\":\"Liquidia Announces Results of Special Meeting of Stockholders - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjQxNyMzODI4MzM1IzIwODQ0NjA=\",\"datePublished\":\"2020-11-16T12:18:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjQxNyMzODI4MzM1IzIwODQ0NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjQxNyMzODI4MzM1IzIwODQ0NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-announces-results-of-special-meeting-of-stockholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Liquidia Announces Results of Special Meeting of Stockholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Liquidia Announces Results of Special Meeting of Stockholders - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/","og_locale":"en_US","og_type":"article","og_title":"Liquidia Announces Results of Special Meeting of Stockholders - Market Newsdesk","og_description":"Stockholders Approve RareGen Acquisition Merger Expected to Close on or A bout November 18 , 2020 RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT\u00ae\u00a0technology, today announced that its stockholders voted to adopt and approve the previously announced merger agreement, dated as of June 29, 2020, among the Company, RareGen, LLC (\u201cRareGen\u201d), Liquidia Corporation (\u201cLiquidia Corporation\u201d), Gemini Merger Sub I, Inc. (\u201cLiquidia Merger Sub\u201d), Gemini Merger Sub II, LLC and PBM RG Holdings, LLC (the \u201cMerger Agreement\u201d), including the merger of the Company with and into Liquidia Merger Sub (the \u201cLiquidia Merger\u201d), with the Company and … Continue reading \"Liquidia Announces Results of Special Meeting of Stockholders\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-16T12:18:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjQxNyMzODI4MzM1IzIwODQ0NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Liquidia Announces Results of Special Meeting of Stockholders","datePublished":"2020-11-16T12:18:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/"},"wordCount":1520,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjQxNyMzODI4MzM1IzIwODQ0NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/","name":"Liquidia Announces Results of Special Meeting of Stockholders - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjQxNyMzODI4MzM1IzIwODQ0NjA=","datePublished":"2020-11-16T12:18:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjQxNyMzODI4MzM1IzIwODQ0NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjQxNyMzODI4MzM1IzIwODQ0NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-announces-results-of-special-meeting-of-stockholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Liquidia Announces Results of Special Meeting of Stockholders"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381493"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381493\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}